Individuals with familial hypercholesterolemia (FH) require early lipid-lowering therapy (LLT). We compared rosuvastatin versus ezetimibe treatment and the role of major non-invasive arterial injury markers in children with heterozygous FH.
In this prospective, open-label, randomized study, 45 children with...
A. Skarlovnik, Tevž Gorjanc, J. Šikonja et al.· Frontiers in Cardiovascular...· 0 citations
Highlights What are the main findings? Juvenile-onset Huntington disease frequently presented with heterogeneous, non-choreic developmental, psychiatric, gait, speech, and movement abnormalities, with a median diagnostic delay of 4 years. Among published patients with ascertainable seizure status, epilepsy was reported...
Mirjana Perkovič Benedik, T. Loboda, Katarina Benedik Kafol et al.· Brain Science· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.